SWITZERLAND: Swiss National Bank raised its position in shares of CVS Health Corporation (NYSE:CVS) by 26.9% during the first quarter, according to its most recent filing with the SEC. The fund owned 3,826,410 shares of the pharmacy operator’s stock after buying an additional 811,100 shares during the period. Swiss National Bank owned 0.36% of CVS Health Corporation worth $300,373,000 as of its most recent SEC filing.
Several other large investors have also recently modified their holdings of CVS. SRS Capital Advisors Inc. purchased a new stake in shares of CVS Health Corporation during the fourth quarter valued at about $120,000. Intellectus Partners LLC purchased a new stake in shares of CVS Health Corporation during the fourth quarter valued at about $917,000. Levin Capital Strategies L.P. boosted its stake in shares of CVS Health Corporation by 6,358.6% in the fourth quarter. Levin Capital Strategies L.P. now owns 523,796 shares of the pharmacy operator’s stock valued at $41,333,000 after buying an additional 515,686 shares during the last quarter. Franklin Resources Inc. boosted its stake in shares of CVS Health Corporation by 19.9% in the fourth quarter. Franklin Resources Inc. now owns 14,288,826 shares of the pharmacy operator’s stock valued at $1,127,532,000 after buying an additional 2,372,019 shares during the last quarter. Finally, A.R.T. Advisors LLC bought a new stake in shares of CVS Health Corporation during the fourth quarter valued at $4,166,000. 82.31% of the stock is currently owned by hedge funds and other institutional investors.
CVS Health Corporation (NYSE:CVS) traded down 0.14% during trading on Monday, hitting $79.30. The company had a trading volume of 3,800,570 shares. The firm’s 50 day moving average is $78.83 and its 200-day moving average is $78.96. The stock has a market capitalization of $80.61 billion, a price-to-earnings ratio of 15.80 and a beta of 0.91. CVS Health Corporation has a 52-week low of $69.30 and a 52-week high of $98.44. CVS Health Corporation (NYSE:CVS) last released its quarterly earnings data on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.31 by $0.02. CVS Health Corporation had a net margin of 2.93% and a return on equity of 17.47%. The business had revenue of $45.69 billion for the quarter, compared to analysts’ expectations of $45.36 billion. During the same quarter last year, the company earned $1.32 EPS. The company’s revenue for the quarter was up 4.5% compared to the same quarter last year. On average, equities analysts forecast that CVS Health Corporation will post $5.88 earnings per share for the current year.
